Cargando…
Prognostic gene network modules in breast cancer hold promise
A substantial proportion of lymph node-negative patients who receive adjuvant chemotherapy do not derive any benefit from this aggressive and potentially toxic treatment. However, standard histopathological indices cannot reliably detect patients at low risk of relapse or distant metastasis. In the...
Autores principales: | Teschendorff, Andrew E, Jiao, Yan, Caldas, Carlos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046436/ https://www.ncbi.nlm.nih.gov/pubmed/21143771 http://dx.doi.org/10.1186/bcr2774 |
Ejemplares similares
-
The breast cancer somatic 'muta-ome': tackling the complexity
por: Teschendorff, Andrew E, et al.
Publicado: (2009) -
Do Infrared Thermometers Hold Promise for an Effective Early Warning System for Emerging Respiratory Infectious Diseases?
por: Li, Rui, et al.
Publicado: (2023) -
A quantum leap in our knowledge of breast cancer mutations
por: Caldas, Carlos, et al.
Publicado: (2006) -
Spermatogonial stem cells: What does the future hold?
por: Tournaye, H., et al.
Publicado: (2011) -
Diagnostic testing holds the key to NTD elimination
por: Boehme, Catharina, et al.
Publicado: (2021)